Regulon 0.15mg/0.03mg 21 tablets — Made in Hungary — Free Delivery

Structure

• desogestrel - 0.15 mg;
• ethinylestradiol - 0.03 mg.

Contraindications

• current venous thromboembolism, in particular due to anticoagulant therapy or a history of (eg deep vein thrombosis (DVT) or pulmonary embolism (PE));
• known hereditary or acquired tendency to venous thromboembolism, such as resistance to activated protein C (including factor V Leiden mutation), antithrombin III deficiency, protein C deficiency, protein S deficiency;
• major surgery with prolonged immobilization;
• high risk of venous thromboembolism due to the presence of multiple risk factors.

• current or history of arterial thromboembolism (eg myocardial infarction) or a prodromal condition (eg angina pectoris);
• cerebrovascular disease - current or history of stroke, or prodromal condition (for example, transient ischemic attack (TIA));
• an established hereditary or acquired tendency to arterial thromboembolism, such as hyperhomocysteinemia and the presence of antiphospholipid antibodies (anticardiolipin antibodies, lupus anticoagulant);
• a history of migraine with focal neurological symptoms;
• high risk of developing ATE due to the presence of multiple risk factors or the presence of one of the following serious risk factors:
• diabetes mellitus with vascular complications;
• severe arterial hypertension;
• severe dyslipoproteinemia.

Mode of application

Application features

Overdose